Transcatheter closure of patent foramen ovale with the Spider™ patent foramen ovale occluder: A prospective, single-center trial

Chinese Medical Journal

Volumn 123, Issue 7, 2010, Pages 834-837

  Zhang, Cao Jin ^a   Huang, Yi Gao ^a   Huang, Xin Sheng ^a   Huang, Tao ^a   Huang, Wen Hui ^a   Shen, Jun Jun ^a   Xun, Zheng Rong ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Follow up; Occluder; Patent foramen ovale

Indexed keywords

ACETYLSALICYLIC ACID;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR EQUIPMENT; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; FEMALE; FLUOROSCOPY; FOLLOW UP; HEART RIGHT LEFT SHUNT; HUMAN; MAJOR CLINICAL STUDY; MALE; PARADOXICAL EMBOLISM; PATENT FORAMEN OVALE; PATENT FORAMEN OVALE OCCLUDER; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADOLESCENT; ADULT; AGED; ASPIRIN; ECHOCARDIOGRAPHY; FEMALE; FORAMEN OVALE, PATENT; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 77950909716     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.07.013     Document Type: Article

References (15)

1. Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988; 318: 1148-1152.
2. Kerut EK, Truax WD, Borreson TE, Van Meter KW, Given MB, Giles TD. Detection of right to left shunts in decompression sickness in divers. Am J Cardiol 1997; 79: 377-378.
3. Falk V, Walther T, Krankenberg H, Mohr FW. Trapped thrombus in a patent foramen ovale. Thorac Cardiovasc Surg 1997; 45: 90-92.
4. Rodriguez CJ, Homma S. Management of patients with stroke and a patent foramen ovale. Curr Cardiol Rep 2004; 6: 143-146.
5. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001; 345: 1740-1746.
6. Schuchlenz HW, Weihs W, Berghold A, Lechner A, Schmidt R. Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale. Int J Cardiol 2005; 101: 77-82.
7. Dearani JA, Ugurlu BS, Danielson GK, Daly RC, McGregor CG, Mullany CJ, et al. Surgical patent foramen ovale closure for prevention of paradoxical embolism-related cerebrovascular ischemic events. Circulation 1999; 100: II171-II175.
8. Braun M, Gliech V, Boscheri A, Schoen S, Gahn G, Reichmann H, et al. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and midterm follow-up results of three different device occluder systems. Eur Heart J 2004; 25: 424-430.
9. Taaffe M, Fischer E, Baranowski A, Majunke N, Heinisch C, Leetz M, et al. Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARflex versus Helex occluder). Am J Cardiol 2008; 101: 1353-1358.
10. Schuchlenz HW, Weihs W, Beitzke A, Stein JI, Gamillscheg A, Rehak P. Transesophageal echocardiography for quantifying size of patent foramen ovale in patients with cryptogenic cerebrovascular events. Stroke 2002; 33: 293-296.
11. Bridges ND, Hellenbrand W, Latson L, Filiano J, Newburger JW, Lock JE. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992; 86: 1902-1908.
12. Wahl A, Kunz M, Moschovitis A, Nageh T, Schwerzmann M, Seiler C, et al. Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism. Heart 2008; 94: 336-341.
13. Spies C, Khandelwal A, Timmemanns I, Kavinsky CJ, Schräder R, Hijazi ZM. Recurrent events following patent foramen ovale closure in patients above 55 years of age with presumed paradoxical embolism. Catheter Cardiovasc Interv 2008; 72: 966-970.
14. Braun MU, Fassbender D, Schoen SP, Haass M, Schraeder R, Scholtz W, et al. Transcatheter closure of patent foramen ovale in patients with cerebral ischemia. J Am Coll Cardiol 2002; 39: 2019-2025.
15. Mas JL, Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack. Am Heart J 1995; 130: 1083-1088.